These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6720461)

  • 1. Methods for reducing undesirable side effects of glucocorticoids.
    Hahn BH; Hahn TJ
    Adv Exp Med Biol; 1984; 171():301-11. PubMed ID: 6720461
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive effects of deflazacort - a new glucocorticoid with bone-sparing and carbohydrate-sparing properties: comparison with prednisone.
    Hahn BH; Pletscher LS; Muniain M
    J Rheumatol; 1981; 8(5):783-90. PubMed ID: 6458701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute changes in urinary radiocalcium following glucocorticoids administration in man.
    Gennari C; Scala C; Imbimbo B; Bernini M; Montagnani M; Nardi P; Fusi L; Avioli LV
    Adv Exp Med Biol; 1984; 171():407-15. PubMed ID: 6372402
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of glucocorticoids and anabolic steroids on cells derived from human skeletal and articular tissues in vitro.
    Gallagher JA; Beresford JN; McGuire MK; Ebsworth NM; Meats JE; Gowen M; Elford P; Wright D; Poser J; Coulton LA
    Adv Exp Med Biol; 1984; 171():279-91. PubMed ID: 6720460
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a new glucocorticoid, deflazacort, on pituitary-adrenal function in man: a comparison with prednisone.
    Criscuolo D; Fraioli F; Bonifacio V; Paolucci D; Isidori A
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):37-41. PubMed ID: 6245036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolism of bone in culture (author's transl)].
    Rebut-Bonneton C; Delbarre F
    Ann Endocrinol (Paris); 1979; 40(2):171-2. PubMed ID: 475312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Evaluation of bone histomorphometry in osteoporotics and age matched controls.
    Lindholm TS; Nilsson OS; Widhe T; Elmsted E; Eriksson S
    Acta Vitaminol Enzymol; 1982; 4(1-2):179-84. PubMed ID: 7124565
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.
    Hahn TJ; Halstead LR; Strates B; Imbimbo B; Baran DT
    Calcif Tissue Int; 1980; 31(2):109-15. PubMed ID: 6770974
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
    J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
    Shiraki M; Fukuchi M; Kiriyama T; Okamoto S; Ueno T; Sakamoto H; Nagai T
    J Bone Miner Metab; 2004; 22(4):352-9. PubMed ID: 15221494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids, glucose metabolism and hypothalamic-pituitary-adrenal axis.
    Wajchenberg BL; Prestes Cesar F; Okada H; Torres de Toledo e Souza I; Lerário AC; Borghi VC; Malerbi DA; Giurna Filho A; Liberman B; Gianella D
    Adv Exp Med Biol; 1984; 171():25-44. PubMed ID: 6372395
    [No Abstract]   [Full Text] [Related]  

  • 13. Corticosteroid-induced osteopenia.
    Hahn TJ
    Arch Intern Med; 1978 May; 138 Spec No():882-5. PubMed ID: 646579
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
    Rotenberger J; Köbberling J
    Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the efficacy of high dose and normal dose budesonide in prednisone dependent patients with chronic obstructive lung disease (COLD).
    Overbeek SE; Hilvering C; Bogaard JM; Birkenhäger JC; Neijens HJ
    Eur J Respir Dis Suppl; 1986; 146():581-4. PubMed ID: 3465583
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
    Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
    J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new glucocorticoid, oxazacort, on some variables connected with bone metabolism in man: a comparison with prednisone.
    Caniggia A; Marchetti M; Gennari C; Vattimo A; Nicolis FB
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):126-34. PubMed ID: 66216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evidence of the calcium-sparing effect of deflazacort.
    Lund B; Pedersen JG; Egsmose C; Lund B
    Adv Exp Med Biol; 1984; 171():149-54. PubMed ID: 6720457
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of glucocorticoids on bone cell metabolism and function.
    Peck WA
    Adv Exp Med Biol; 1984; 171():111-9. PubMed ID: 6372390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.